will focus on high-dose therapy. Among the topics and authors are:
"Manipulating the Immune Attributes of Both Graft and Host to Improve
Transplant Outcome," by Stephen J. Noga, MD, PhD, and Paul V. O’Donnell,
MD, PhD, at The Johns Hopkins Oncology Center;
"High-Dose Chemotherapy in the Adjuvant Treatment of Breast Cancer:
Benefit/Risk Analysis" by Benjamin Djulbegovic, MD, at the James Graham
Brown Cancer Center; Istok Hozo, MD, at Indiana University; and Karen K.
Fields, MD, and Daniel Sullivan, MD, at the H. Lee Moffitt Cancer Center
& Research Institute;
"Detection and Clinical Significance of Minimal Residual Disease in
Transplant Patients With Breast Cancer, Lymphoma, and Multiple Myeloma,"
by Thomas J. Moss, MD, at the University of Southern California; and
"Radiation-Induced Sarcoma Following Treatment of Breast Cancer: A Case
Report and Review of the Literature," by Christiana M. Brenin, MD,
Mark S. Talamonti, MD, William Small, Jr, MD, and William J. Gradishar,
MD, at the Robert H. Lurie Cancer Center.
The regular departments of
Cancer Control will feature Cancer Economics,
Clinical Research Protocols for High-Dose Therapy, Oncology Pharmacotherapy,
Imaging in Oncology, Ten Best Readings on High-Dose Therapy, Clinical Diagnosis,
and Infections in Oncology.
© Copyright 1996 - 2008 H. Lee Moffitt Cancer Center & Research Institute